No abstract available
Publication types
-
Case Reports
-
Letter
-
Research Support, N.I.H., Intramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenosine Deaminase / deficiency*
-
Adenosine Deaminase / genetics
-
Adult
-
Agammaglobulinemia / drug therapy
-
Agammaglobulinemia / genetics*
-
Anti-Inflammatory Agents / therapeutic use
-
Autoimmunity
-
Child
-
Child, Preschool
-
Etanercept / therapeutic use
-
Genotype*
-
Homozygote
-
Humans
-
Inflammation
-
Intercellular Signaling Peptides and Proteins / genetics*
-
Male
-
Mutation / genetics*
-
Pedigree
-
Phenotype
-
Severe Combined Immunodeficiency / drug therapy
-
Severe Combined Immunodeficiency / genetics*
-
Skin / pathology*
-
Warts / drug therapy
-
Warts / genetics*
Substances
-
Anti-Inflammatory Agents
-
Intercellular Signaling Peptides and Proteins
-
ADA2 protein, human
-
Adenosine Deaminase
-
Etanercept
Supplementary concepts
-
Severe combined immunodeficiency due to adenosine deaminase deficiency